APCCDC20-mediated degradation of PHD3 stabilizes HIF-1a and promotes tumorigenesis in hepatocellular carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
APCCDC20-mediated degradation of PHD3 stabilizes HIF-1a and promotes tumorigenesis in hepatocellular carcinoma
Authors
Keywords
Hypoxia-inducible factor-1, Destruction-box, Fluorescence-based multiplex immunohistochemistry, WGCNA
Journal
CANCER LETTERS
Volume 496, Issue -, Pages 144-155
Publisher
Elsevier BV
Online
2020-10-09
DOI
10.1016/j.canlet.2020.10.011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SENP1-mediated deSUMOylation of USP28 regulated HIF-1α accumulation and activation during hypoxia response
- (2019) Shi-chun Du et al. Cancer Cell International
- Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth
- (2019) Yu Wang et al. FASEB JOURNAL
- FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression
- (2019) Guohui Hu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Interaction of transforming growth factor-β-Smads/microRNA-362-3p/CD82 mediated by M2 macrophages promotes the process of epithelial-mesenchymal transition in hepatocellular carcinoma cells
- (2019) Qinghui Zhang et al. CANCER SCIENCE
- Sustained ER stress promotes hyperglycemia by increasing glucagon action through the deubiquitinating enzyme USP14
- (2019) Bin Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma
- (2018) Mingqin Lu et al. IUBMB LIFE
- Up-regulated and interrelated expressions of GINS subunits predict poor prognosis in hepatocellular carcinoma
- (2018) Yi-Fan Lian et al. BIOSCIENCE REPORTS
- Silencing TRIP13 inhibits cell growth and metastasis of hepatocellular carcinoma by activating of TGF-β1/smad3
- (2018) Jianning Yao et al. Cancer Cell International
- SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop
- (2017) Chun-Ping Cui et al. GUT
- Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma
- (2017) Mingyang Ma et al. Oncotarget
- Prognostic significance of synergistic hexokinase-2 and beta2-adrenergic receptor expression in human hepatocelluar carcinoma after curative resection
- (2016) Zhi-Feng Zhang et al. BMC GASTROENTEROLOGY
- PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
- (2016) Natalie J. German et al. MOLECULAR CELL
- Insights into APC/C: from cellular function to diseases and therapeutics
- (2016) Zhuan Zhou et al. Cell Division
- Targeting Cdc20 as a novel cancer therapeutic strategy
- (2015) Lixia Wang et al. PHARMACOLOGY & THERAPEUTICS
- Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells
- (2015) Susanne Lub et al. Oncotarget
- The E3 ligase APC/C-Cdh1 regulates MEF2A-dependent transcription by targeting SUMO-specific protease 2 for ubiquitination and degradation
- (2014) Han Lu et al. CELL CYCLE
- Increased CDC20 expression is associated with development and progression of hepatocellular carcinoma
- (2014) JIA LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C
- (2014) Katharine L. Sackton et al. NATURE
- Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis
- (2013) Colin Clarke et al. CARCINOGENESIS
- Cdc20: A Potential Novel Therapeutic Target for Cancer Treatment
- (2013) Zhiwei Wang et al. CURRENT PHARMACEUTICAL DESIGN
- The Beta2-Adrenergic Receptor is a Potential Prognostic Biomarker for Human Hepatocellular Carcinoma After Curative Resection
- (2012) Dongtai Chen et al. ANNALS OF SURGICAL ONCOLOGY
- Proteomic Identification of Common SCF Ubiquitin Ligase FBXO6-Interacting Glycoproteins in Three kinds of Cells
- (2012) Bin Liu et al. JOURNAL OF PROTEOME RESEARCH
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- The expression of prolyl hydroxylase domain enzymes are up-regulated and negatively correlated with Bcl-2 in non-small cell lung cancer
- (2011) Sufeng Chen et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival
- (2011) Sigve Andersen et al. PLoS One
- Cyclin A and Nek2A: APC/C–Cdc20 substrates invisible to the mitotic spindle checkpoint
- (2010) Wouter van Zon et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancer
- (2010) Y Su et al. BRITISH JOURNAL OF CANCER
- Tumor Vasculature Is Regulated by PHD2-Mediated Angiogenesis and Bone Marrow-Derived Cell Recruitment
- (2009) Denise A. Chan et al. CANCER CELL
- Prolyl Hydroxylase-3 Is Down-regulated in Colorectal Cancer Cells and Inhibits IKKβ Independent of Hydroxylase Activity
- (2009) Jing Xue et al. GASTROENTEROLOGY
- Oxygen-Regulated 2-Adrenergic Receptor Hydroxylation by EGLN3 and Ubiquitylation by pVHL
- (2009) L. Xie et al. Science Signaling
- WGCNA: an R package for weighted correlation network analysis
- (2008) Peter Langfelder et al. BMC BIOINFORMATICS
- HIF-1 regulation: not so easy come, easy go
- (2008) Mei Yee Koh et al. TRENDS IN BIOCHEMICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started